Cigna-Express Scripts Combination Makes Sense, Jim Cramer Says

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer is fond of Cigna's (CIG)  plans to purchase Express Scripts (ESRX) for $67 billion and thinks Cigna shares are a buy.

"The accretion is so great here that people should be buying Cigna right here," Cramer noted.

Want more exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Watch all of Jim Cramer's full NYSE live shows right here: